Tymlos and Pulse abnormal - a phase IV clinical study of FDA data

Summary:

Pulse abnormal is reported as a side effect among people who take Tymlos (abaloparatide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Actemra, and have Osteoporosis post-menopausal.

The phase IV clinical study analyzes which people have Pulse abnormal when taking Tymlos. It is created by eHealthMe based on reports of 16,502 people who have side effects when taking Tymlos from the FDA, and is updated regularly.

What is Tymlos?

Tymlos has active ingredients of abaloparatide. eHealthMe is studying from 16,516 Tymlos users. Check the latest studies of Tymlos.

What is Pulse abnormal?

Pulse abnormal is found to be associated with 436 drugs and 490 conditions by eHealthMe. Check the latest studies of Pulse abnormal.

On Jul, 26, 2026

16,502 people reported to have side effects when taking Tymlos.
Among them, 22 people (0.13%) have Pulse abnormal.

Among these 22 people:

How long have people been on Tymlos when they have Pulse abnormal? *

What is the gender of people who have Pulse abnormal when taking Tymlos? *

female: 95.45 %
male: 4.55 %

What is the age of people who have Pulse abnormal when taking Tymlos? *

What are other drugs people take besides Tymlos? *

What are other side effects people have besides Pulse abnormal? *

Heart Rate Increased: 12 people, 54.55%
Headache (pain in head): 12 people, 54.55%
Dizziness: 9 people, 40.91%
Fatigue (feeling of tiredness): 9 people, 40.91%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 6 people, 27.27%
Joint Pain: 6 people, 27.27%
Back Pain: 5 people, 22.73%
Insomnia (sleeplessness): 5 people, 22.73%
High Blood Pressure: 5 people, 22.73%
Sensory Disturbance (sense disturbance): 4 people, 18.18%

What are the existing conditions these people have? *

Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 8 people, 36.36%
Senile Osteoporosis (weak bones with ageing): 6 people, 27.27%
Osteoporosis (bones weak and more likely to break): 6 people, 27.27%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 13.64%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 13.64%
Breast Cancer: 2 people, 9.09%
Spinal Fracture (fracture in one of vertebrae): 1 person, 4.55%
Pathological Fracture (broken bone caused by disease): 1 person, 4.55%
Back Pain: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Tymlos and have Pulse abnormal?

- Check whether Pulse abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tymlos:

Tymlos (16,516 reports)

Pulse abnormal treatments and more:

Pulse abnormal (2,933 reports)

Browse all side effects of Tymlos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulse abnormal:

Pulse abnormal (436 drugs)

Browse all the conditions that are associated with Pulse abnormal:

Pulse abnormal (490 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abaloparatide (the active ingredients of Tymlos) and Tymlos (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.